img

Global Infectious Enteritis Treatment Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Infectious Enteritis Treatment Market Research Report 2024

According to MRAResearch’s new survey, global Infectious Enteritis Treatment market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Infectious Enteritis Treatment market research.
Key companies engaged in the Infectious Enteritis Treatment industry include Abbott Laboratories, Baxter International, Pfizer, Bristol-Myers Squibb, Actelion Pharmaceuticals, Merck & Company, Lonza, BioGaia and ZBiotics, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Infectious Enteritis Treatment were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Infectious Enteritis Treatment market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Infectious Enteritis Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Abbott Laboratories
Baxter International
Pfizer
Bristol-Myers Squibb
Actelion Pharmaceuticals
Merck & Company
Lonza
BioGaia
ZBiotics
Evolve Biosystems
Segment by Type
Antibiotics
Ampicillin
Chloramphenicol
Other

Segment by Application


Hospital Pharmacy
Online Pharmacy
Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Infectious Enteritis Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infectious Enteritis Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Antibiotics
1.2.3 Ampicillin
1.2.4 Chloramphenicol
1.2.5 Other
1.3 Market by Application
1.3.1 Global Infectious Enteritis Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital Pharmacy
1.3.3 Online Pharmacy
1.3.4 Pharmacy
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Infectious Enteritis Treatment Market Perspective (2018-2033)
2.2 Infectious Enteritis Treatment Growth Trends by Region
2.2.1 Global Infectious Enteritis Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Infectious Enteritis Treatment Historic Market Size by Region (2018-2023)
2.2.3 Infectious Enteritis Treatment Forecasted Market Size by Region (2024-2033)
2.3 Infectious Enteritis Treatment Market Dynamics
2.3.1 Infectious Enteritis Treatment Industry Trends
2.3.2 Infectious Enteritis Treatment Market Drivers
2.3.3 Infectious Enteritis Treatment Market Challenges
2.3.4 Infectious Enteritis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infectious Enteritis Treatment Players by Revenue
3.1.1 Global Top Infectious Enteritis Treatment Players by Revenue (2018-2023)
3.1.2 Global Infectious Enteritis Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Infectious Enteritis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Infectious Enteritis Treatment Revenue
3.4 Global Infectious Enteritis Treatment Market Concentration Ratio
3.4.1 Global Infectious Enteritis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infectious Enteritis Treatment Revenue in 2022
3.5 Infectious Enteritis Treatment Key Players Head office and Area Served
3.6 Key Players Infectious Enteritis Treatment Product Solution and Service
3.7 Date of Enter into Infectious Enteritis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Infectious Enteritis Treatment Breakdown Data by Type
4.1 Global Infectious Enteritis Treatment Historic Market Size by Type (2018-2023)
4.2 Global Infectious Enteritis Treatment Forecasted Market Size by Type (2024-2033)
5 Infectious Enteritis Treatment Breakdown Data by Application
5.1 Global Infectious Enteritis Treatment Historic Market Size by Application (2018-2023)
5.2 Global Infectious Enteritis Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Infectious Enteritis Treatment Market Size (2018-2033)
6.2 North America Infectious Enteritis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Infectious Enteritis Treatment Market Size by Country (2018-2023)
6.4 North America Infectious Enteritis Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Infectious Enteritis Treatment Market Size (2018-2033)
7.2 Europe Infectious Enteritis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Infectious Enteritis Treatment Market Size by Country (2018-2023)
7.4 Europe Infectious Enteritis Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Infectious Enteritis Treatment Market Size (2018-2033)
8.2 Asia-Pacific Infectious Enteritis Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Infectious Enteritis Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Infectious Enteritis Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Infectious Enteritis Treatment Market Size (2018-2033)
9.2 Latin America Infectious Enteritis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Infectious Enteritis Treatment Market Size by Country (2018-2023)
9.4 Latin America Infectious Enteritis Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infectious Enteritis Treatment Market Size (2018-2033)
10.2 Middle East & Africa Infectious Enteritis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Infectious Enteritis Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Infectious Enteritis Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Infectious Enteritis Treatment Introduction
11.1.4 Abbott Laboratories Revenue in Infectious Enteritis Treatment Business (2018-2023)
11.1.5 Abbott Laboratories Recent Development
11.2 Baxter International
11.2.1 Baxter International Company Detail
11.2.2 Baxter International Business Overview
11.2.3 Baxter International Infectious Enteritis Treatment Introduction
11.2.4 Baxter International Revenue in Infectious Enteritis Treatment Business (2018-2023)
11.2.5 Baxter International Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Infectious Enteritis Treatment Introduction
11.3.4 Pfizer Revenue in Infectious Enteritis Treatment Business (2018-2023)
11.3.5 Pfizer Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Detail
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Infectious Enteritis Treatment Introduction
11.4.4 Bristol-Myers Squibb Revenue in Infectious Enteritis Treatment Business (2018-2023)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Actelion Pharmaceuticals
11.5.1 Actelion Pharmaceuticals Company Detail
11.5.2 Actelion Pharmaceuticals Business Overview
11.5.3 Actelion Pharmaceuticals Infectious Enteritis Treatment Introduction
11.5.4 Actelion Pharmaceuticals Revenue in Infectious Enteritis Treatment Business (2018-2023)
11.5.5 Actelion Pharmaceuticals Recent Development
11.6 Merck & Company
11.6.1 Merck & Company Company Detail
11.6.2 Merck & Company Business Overview
11.6.3 Merck & Company Infectious Enteritis Treatment Introduction
11.6.4 Merck & Company Revenue in Infectious Enteritis Treatment Business (2018-2023)
11.6.5 Merck & Company Recent Development
11.7 Lonza
11.7.1 Lonza Company Detail
11.7.2 Lonza Business Overview
11.7.3 Lonza Infectious Enteritis Treatment Introduction
11.7.4 Lonza Revenue in Infectious Enteritis Treatment Business (2018-2023)
11.7.5 Lonza Recent Development
11.8 BioGaia
11.8.1 BioGaia Company Detail
11.8.2 BioGaia Business Overview
11.8.3 BioGaia Infectious Enteritis Treatment Introduction
11.8.4 BioGaia Revenue in Infectious Enteritis Treatment Business (2018-2023)
11.8.5 BioGaia Recent Development
11.9 ZBiotics
11.9.1 ZBiotics Company Detail
11.9.2 ZBiotics Business Overview
11.9.3 ZBiotics Infectious Enteritis Treatment Introduction
11.9.4 ZBiotics Revenue in Infectious Enteritis Treatment Business (2018-2023)
11.9.5 ZBiotics Recent Development
11.10 Evolve Biosystems
11.10.1 Evolve Biosystems Company Detail
11.10.2 Evolve Biosystems Business Overview
11.10.3 Evolve Biosystems Infectious Enteritis Treatment Introduction
11.10.4 Evolve Biosystems Revenue in Infectious Enteritis Treatment Business (2018-2023)
11.10.5 Evolve Biosystems Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Infectious Enteritis Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Antibiotics
Table 3. Key Players of Ampicillin
Table 4. Key Players of Chloramphenicol
Table 5. Key Players of Other
Table 6. Global Infectious Enteritis Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Infectious Enteritis Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Infectious Enteritis Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Infectious Enteritis Treatment Market Share by Region (2018-2023)
Table 10. Global Infectious Enteritis Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Infectious Enteritis Treatment Market Share by Region (2024-2033)
Table 12. Infectious Enteritis Treatment Market Trends
Table 13. Infectious Enteritis Treatment Market Drivers
Table 14. Infectious Enteritis Treatment Market Challenges
Table 15. Infectious Enteritis Treatment Market Restraints
Table 16. Global Infectious Enteritis Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Infectious Enteritis Treatment Market Share by Players (2018-2023)
Table 18. Global Top Infectious Enteritis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Enteritis Treatment as of 2022)
Table 19. Ranking of Global Top Infectious Enteritis Treatment Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Infectious Enteritis Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Infectious Enteritis Treatment Product Solution and Service
Table 23. Date of Enter into Infectious Enteritis Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Infectious Enteritis Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Infectious Enteritis Treatment Revenue Market Share by Type (2018-2023)
Table 27. Global Infectious Enteritis Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Infectious Enteritis Treatment Revenue Market Share by Type (2024-2033)
Table 29. Global Infectious Enteritis Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Infectious Enteritis Treatment Revenue Market Share by Application (2018-2023)
Table 31. Global Infectious Enteritis Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Infectious Enteritis Treatment Revenue Market Share by Application (2024-2033)
Table 33. North America Infectious Enteritis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Infectious Enteritis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Infectious Enteritis Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Infectious Enteritis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Infectious Enteritis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Infectious Enteritis Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Infectious Enteritis Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Infectious Enteritis Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Infectious Enteritis Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Infectious Enteritis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Infectious Enteritis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Infectious Enteritis Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Infectious Enteritis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Infectious Enteritis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Infectious Enteritis Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 48. Abbott Laboratories Company Detail
Table 49. Abbott Laboratories Business Overview
Table 50. Abbott Laboratories Infectious Enteritis Treatment Product
Table 51. Abbott Laboratories Revenue in Infectious Enteritis Treatment Business (2018-2023) & (US$ Million)
Table 52. Abbott Laboratories Recent Development
Table 53. Baxter International Company Detail
Table 54. Baxter International Business Overview
Table 55. Baxter International Infectious Enteritis Treatment Product
Table 56. Baxter International Revenue in Infectious Enteritis Treatment Business (2018-2023) & (US$ Million)
Table 57. Baxter International Recent Development
Table 58. Pfizer Company Detail
Table 59. Pfizer Business Overview
Table 60. Pfizer Infectious Enteritis Treatment Product
Table 61. Pfizer Revenue in Infectious Enteritis Treatment Business (2018-2023) & (US$ Million)
Table 62. Pfizer Recent Development
Table 63. Bristol-Myers Squibb Company Detail
Table 64. Bristol-Myers Squibb Business Overview
Table 65. Bristol-Myers Squibb Infectious Enteritis Treatment Product
Table 66. Bristol-Myers Squibb Revenue in Infectious Enteritis Treatment Business (2018-2023) & (US$ Million)
Table 67. Bristol-Myers Squibb Recent Development
Table 68. Actelion Pharmaceuticals Company Detail
Table 69. Actelion Pharmaceuticals Business Overview
Table 70. Actelion Pharmaceuticals Infectious Enteritis Treatment Product
Table 71. Actelion Pharmaceuticals Revenue in Infectious Enteritis Treatment Business (2018-2023) & (US$ Million)
Table 72. Actelion Pharmaceuticals Recent Development
Table 73. Merck & Company Company Detail
Table 74. Merck & Company Business Overview
Table 75. Merck & Company Infectious Enteritis Treatment Product
Table 76. Merck & Company Revenue in Infectious Enteritis Treatment Business (2018-2023) & (US$ Million)
Table 77. Merck & Company Recent Development
Table 78. Lonza Company Detail
Table 79. Lonza Business Overview
Table 80. Lonza Infectious Enteritis Treatment Product
Table 81. Lonza Revenue in Infectious Enteritis Treatment Business (2018-2023) & (US$ Million)
Table 82. Lonza Recent Development
Table 83. BioGaia Company Detail
Table 84. BioGaia Business Overview
Table 85. BioGaia Infectious Enteritis Treatment Product
Table 86. BioGaia Revenue in Infectious Enteritis Treatment Business (2018-2023) & (US$ Million)
Table 87. BioGaia Recent Development
Table 88. ZBiotics Company Detail
Table 89. ZBiotics Business Overview
Table 90. ZBiotics Infectious Enteritis Treatment Product
Table 91. ZBiotics Revenue in Infectious Enteritis Treatment Business (2018-2023) & (US$ Million)
Table 92. ZBiotics Recent Development
Table 93. Evolve Biosystems Company Detail
Table 94. Evolve Biosystems Business Overview
Table 95. Evolve Biosystems Infectious Enteritis Treatment Product
Table 96. Evolve Biosystems Revenue in Infectious Enteritis Treatment Business (2018-2023) & (US$ Million)
Table 97. Evolve Biosystems Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Infectious Enteritis Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Infectious Enteritis Treatment Market Share by Type: 2022 VS 2033
Figure 3. Antibiotics Features
Figure 4. Ampicillin Features
Figure 5. Chloramphenicol Features
Figure 6. Other Features
Figure 7. Global Infectious Enteritis Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Infectious Enteritis Treatment Market Share by Application: 2022 VS 2033
Figure 9. Hospital Pharmacy Case Studies
Figure 10. Online Pharmacy Case Studies
Figure 11. Pharmacy Case Studies
Figure 12. Other Case Studies
Figure 13. Infectious Enteritis Treatment Report Years Considered
Figure 14. Global Infectious Enteritis Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Infectious Enteritis Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Infectious Enteritis Treatment Market Share by Region: 2022 VS 2033
Figure 17. Global Infectious Enteritis Treatment Market Share by Players in 2022
Figure 18. Global Top Infectious Enteritis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Enteritis Treatment as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Infectious Enteritis Treatment Revenue in 2022
Figure 20. North America Infectious Enteritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Infectious Enteritis Treatment Market Share by Country (2018-2033)
Figure 22. United States Infectious Enteritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Infectious Enteritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Infectious Enteritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Infectious Enteritis Treatment Market Share by Country (2018-2033)
Figure 26. Germany Infectious Enteritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France Infectious Enteritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. Infectious Enteritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy Infectious Enteritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia Infectious Enteritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries Infectious Enteritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Infectious Enteritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Infectious Enteritis Treatment Market Share by Region (2018-2033)
Figure 34. China Infectious Enteritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan Infectious Enteritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea Infectious Enteritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia Infectious Enteritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India Infectious Enteritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia Infectious Enteritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Infectious Enteritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Infectious Enteritis Treatment Market Share by Country (2018-2033)
Figure 42. Mexico Infectious Enteritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil Infectious Enteritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Infectious Enteritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Infectious Enteritis Treatment Market Share by Country (2018-2033)
Figure 46. Turkey Infectious Enteritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia Infectious Enteritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Abbott Laboratories Revenue Growth Rate in Infectious Enteritis Treatment Business (2018-2023)
Figure 49. Baxter International Revenue Growth Rate in Infectious Enteritis Treatment Business (2018-2023)
Figure 50. Pfizer Revenue Growth Rate in Infectious Enteritis Treatment Business (2018-2023)
Figure 51. Bristol-Myers Squibb Revenue Growth Rate in Infectious Enteritis Treatment Business (2018-2023)
Figure 52. Actelion Pharmaceuticals Revenue Growth Rate in Infectious Enteritis Treatment Business (2018-2023)
Figure 53. Merck & Company Revenue Growth Rate in Infectious Enteritis Treatment Business (2018-2023)
Figure 54. Lonza Revenue Growth Rate in Infectious Enteritis Treatment Business (2018-2023)
Figure 55. BioGaia Revenue Growth Rate in Infectious Enteritis Treatment Business (2018-2023)
Figure 56. ZBiotics Revenue Growth Rate in Infectious Enteritis Treatment Business (2018-2023)
Figure 57. Evolve Biosystems Revenue Growth Rate in Infectious Enteritis Treatment Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed